I think it's amusing watching some people (esp on the other board) predicting share prices of CTIX over the next several years.
The fact is that no one knows what could happen with successful P2's/P3's.
I still look at Intercept Pharma back in 2014/Jan and what happened when a P2 interim analysis was so good they ended the trial.
Here's a link that I found interesting on that as well as Galt's approach.
Don't think it could happen to CTIX ? Think again.
http://secfilings.com/News.aspx?title=leading...p;naid=703
Kelt
The fact is that no one knows what could happen with successful P2's/P3's.
I still look at Intercept Pharma back in 2014/Jan and what happened when a P2 interim analysis was so good they ended the trial.
Here's a link that I found interesting on that as well as Galt's approach.
Don't think it could happen to CTIX ? Think again.
http://secfilings.com/News.aspx?title=leading...p;naid=703
Kelt
3